Alternate-day oral therapy with TS-1 for advanced gastric cancer

[1]  H. Nagai,et al.  [Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma]. , 2002, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  M. Christian,et al.  [New guidelines to evaluate the response to treatment in solid tumors]. , 2000, Bulletin du cancer.

[3]  T. Taguchi,et al.  Conceptual Changes in Cancer Chemotherapy: From an Oral Fluoropyrimidine Prodrug, UFT, to a Novel Oral Fluoropyrimidine Prodrug, S-1, and Low-Dose FP Therapy in Japan , 2000, Investigational New Drugs.

[4]  T. Shirasaka.  Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic. , 2000, Gan to kagaku ryoho. Cancer & chemotherapy.

[5]  M. Kurihara,et al.  Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer , 2000, Oncology.

[6]  K. Hirata,et al.  Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  K. Sugimachi,et al.  Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. , 1998, European journal of cancer.

[8]  S. Pyrhönen,et al.  Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. , 1995, British Journal of Cancer.

[9]  U. Haglund,et al.  Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  A. Petroianu,et al.  Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer , 1993, Cancer.

[11]  H. Skipper,et al.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. , 1964, Cancer chemotherapy reports.

[12]  M. Lipkin,et al.  CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. II. CELL RENEWAL IN STOMACH, ILEUM, COLON, AND RECTUM. , 1963, Gastroenterology.